A citation-based method for searching scientific literature

Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins, Roman G Rubio, Jason S Ehrlich. Ophthalmology 2012
Times Cited: 1000







List of co-cited articles
584 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
868
39

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
873
36

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller,[...]. Ophthalmology 2010
918
30

Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jeffrey S Heier, Edoardo Midena, Peter K Kaiser, Hiroko Terasaki, Dennis M Marcus,[...]. Ophthalmology 2014
456
28

Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Jeffrey S Heier, Jean-François Korobelnik, David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Edoardo Midena, David S Boyer, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2016
185
27

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Neil M Bressler, Susan B Bressler, Alexander J Brucker, Frederick L Ferris, G Robert Hampton, Chirag Jhaveri,[...]. Ophthalmology 2016
454
24

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
23

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
David S Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K Maturi, Albert J Augustin, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup. Ophthalmology 2014
602
21

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
David M Brown, Quan Dong Nguyen, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Patricio G Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G Rubio,[...]. Ophthalmology 2013
533
21

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.
Pascale Massin, Francesco Bandello, Justus G Garweg, Lutz L Hansen, Simon P Harding, Michael Larsen, Paul Mitchell, Dianne Sharp, U E K Wolf-Schnurrbusch, Margarita Gekkieva,[...]. Diabetes Care 2010
476
18

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Jose Garcia-Arumi, Francesco Bandello, Karina Berg, Usha Chakravarthy, Bianca S Gerendas, Jost Jonas, Michael Larsen, Ramin Tadayoni, Anat Loewenstein. Ophthalmologica 2017
236
17

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Lee M Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N Antoszyk, Carl W Baker, Brian B Berger, Neil M Bressler, David Browning,[...]. JAMA 2015
387
16

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Frank G Holz, David S Boyer, Edoardo Midena, Jeffrey S Heier, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2015
293
16

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Raj K Maturi, Adam R Glassman, Danni Liu, Roy W Beck, Abdhish R Bhavsar, Neil M Bressler, Lee M Jampol, Michele Melia, Omar S Punjabi, Hani Salehi-Had,[...]. JAMA Ophthalmol 2018
100
15

Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
Jennifer K Sun, Michael M Lin, Jan Lammer, Sonja Prager, Rutuparna Sarangi, Paolo S Silva, Lloyd Paul Aiello. JAMA Ophthalmol 2014
227
14

Ranibizumab for neovascular age-related macular degeneration.
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
14

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study.
Christian Prünte, Franck Fajnkuchen, Sajjad Mahmood, Federico Ricci, Katja Hatz, Jan Studnička, Vladimir Bezlyak, Soumil Parikh, William John Stubbings, Andreas Wenzel,[...]. Br J Ophthalmol 2016
97
13

Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
Arup Das, Paul G McGuire, Sampathkumar Rangasamy. Ophthalmology 2015
250
12


Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Danni Liu, Jennifer K Sun, Andrew N Antoszyk, Carl W Baker, Neil M Bressler, Michael J Elman, Frederick L Ferris, Thomas W Gardner,[...]. JAMA Ophthalmol 2018
149
10

Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.
Ursula Schmidt-Erfurth, Gabriele E Lang, Frank G Holz, Reinier O Schlingemann, Paolo Lanzetta, Pascale Massin, Ortrud Gerstner, Abdelkader Si Bouazza, Haige Shen, Aaron Osborne,[...]. Ophthalmology 2014
208
10

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, Andrew N Antoszyk, David J Browning, Kakarla V Chalam, Sandeep Grover, Lee M Jampol, Chirag D Jhaveri, Michele Melia,[...]. JAMA 2019
95
10

Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States.
Thomas A Ciulla, Peter Bracha, John Pollack, David F Williams. Ophthalmol Retina 2018
58
15

Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
Nancy M Holekamp, Joanna Campbell, Arghavan Almony, Herbert Ingraham, Steven Marks, Hitesh Chandwani, Ashley L Cole, Szilárd Kiss. Am J Ophthalmol 2018
44
20

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
Neil M Bressler, Wesley T Beaulieu, Adam R Glassman, Kevin J Blinder, Susan B Bressler, Lee M Jampol, Michele Melia, John A Wells. JAMA Ophthalmol 2018
111
9

Association of vitreous inflammatory factors with diabetic macular edema.
Hideharu Funatsu, Hidetaka Noma, Tatsuya Mimura, Shuichiro Eguchi, Sadao Hori. Ophthalmology 2009
282
9

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
L P Aiello, R L Avery, P G Arrigg, B A Keyt, H D Jampel, S T Shah, L R Pasquale, H Thieme, M A Iwamoto, J E Park. N Engl J Med 1994
9

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.
Quan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, Roomasa Channa, Elham Hatef, Diana V Do, David Boyer, Jeffery S Heier, Prema Abraham, Allen B Thach,[...]. Ophthalmology 2010
363
9

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.
Peter A Campochiaro, Jeffrey S Heier, Leonard Feiner, Sarah Gray, Namrata Saroj, Amy Chen Rundle, Wendy Yee Murahashi, Roman G Rubio. Ophthalmology 2010
586
9

Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes.
John F Payne, Charles C Wykoff, W Lloyd Clark, Beau B Bruce, David S Boyer, David M Brown. Am J Ophthalmol 2019
28
28

Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
Joan-En Chang-Lin, Mayssa Attar, Andrew A Acheampong, Michael R Robinson, Scott M Whitcup, Baruch D Kuppermann, Devin Welty. Invest Ophthalmol Vis Sci 2011
344
8


Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, Szilárd Kiss, Anat Loewenstein, Albert J Augustin, Julia Ma, Allen C Ho, Vaishali Patel, Scott M Whitcup,[...]. Am J Ophthalmol 2016
166
8

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
Ryan Lee, Tien Y Wong, Charumathi Sabanayagam. Eye Vis (Lond) 2015
557
8

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).
Adam R Glassman, John A Wells, Kristin Josic, Maureen G Maguire, Andrew N Antoszyk, Carl Baker, Wesley T Beaulieu, Michael J Elman, Lee M Jampol, Jennifer K Sun. Ophthalmology 2020
23
34

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
C P Wilkinson, Frederick L Ferris, Ronald E Klein, Paul P Lee, Carl David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram, Juan T Verdaguer. Ophthalmology 2003
7

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Neil M Bressler, Haijing Qin, Roy W Beck, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Ingrid U Scott, Cynthia R Stockdale, Jennifer K Sun. Ophthalmology 2011
389
7

Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.
Susan B Bressler, Allison R Ayala, Neil M Bressler, Michele Melia, Haijing Qin, Frederick L Ferris, Christina J Flaxel, Scott M Friedman, Adam R Glassman, Lee M Jampol,[...]. JAMA Ophthalmol 2016
95
7

Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.
Susan B Bressler, Haijing Qin, Roy W Beck, Kakarla V Chalam, Judy E Kim, Michele Melia, John A Wells. Arch Ophthalmol 2012
178
7

Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
Tien Y Wong, Jennifer Sun, Ryo Kawasaki, Paisan Ruamviboonsuk, Neeru Gupta, Van Charles Lansingh, Mauricio Maia, Wanjiku Mathenge, Sunil Moreker, Mahi M K Muqit,[...]. Ophthalmology 2018
195
7

OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Dinah Zur, Matias Iglicki, Catharina Busch, Alessandro Invernizzi, Miriana Mariussi, Anat Loewenstein. Ophthalmology 2018
99
7

The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema.
Catherine Egan, Haogang Zhu, Aaron Lee, Dawn Sim, Danny Mitry, Clare Bailey, Robert Johnston, Usha Chakravarthy, Alastair Denniston, Adnan Tufail,[...]. Br J Ophthalmol 2017
41
17

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.
David J Browning, Adam R Glassman, Lloyd Paul Aiello, Roy W Beck, David M Brown, Donald S Fong, Neil M Bressler, Ronald P Danis, James L Kinyoun, Quan Dong Nguyen,[...]. Ophthalmology 2007
389
7

One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.
Diana V Do, Quan Dong Nguyen, David Boyer, Ursula Schmidt-Erfurth, David M Brown, Robert Vitti, Alyson J Berliner, Bo Gao, Oliver Zeitz, Rene Ruckert,[...]. Ophthalmology 2012
256
7

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.
Jayashree Sahni, Sunil S Patel, Pravin U Dugel, Arshad M Khanani, Chirag D Jhaveri, Charles C Wykoff, Vrinda S Hershberger, Meike Pauly-Evers, Shamil Sadikhov, Piotr Szczesny,[...]. Ophthalmology 2019
77
9

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Sanford Chen, David Boyer, Jose Ruiz-Moreno, Bruce Garretson, Amod Gupta, Seenu M Hariprasad, Clare Bailey,[...]. Ophthalmology 2012
300
7

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.
David M Brown, Peter A Campochiaro, Rishi P Singh, Zhengrong Li, Sarah Gray, Namrata Saroj, Amy Chen Rundle, Roman G Rubio, Wendy Yee Murahashi. Ophthalmology 2010
550
7

Diabetic retinopathy.
David A Antonetti, Ronald Klein, Thomas W Gardner. N Engl J Med 2012
976
7

OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.
Yi-Ting Hsieh, Minhaj Nur Alam, David Le, Chia-Chieh Hsiao, Chang-Hao Yang, Daniel L Chao, Xincheng Yao. Ophthalmol Retina 2019
35
17

Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year Outcomes.
John F Payne, Charles C Wykoff, W Lloyd Clark, Beau B Bruce, David S Boyer, David M Brown. Ophthalmology 2017
48
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.